Cislini Jeffinsider trades
In SEC Form 4 filings, Cislini Jeff is listed as SVP & General Counsel of Revolution Medicines, Inc. (RVMD). In the last 90 days, Cislini Jeff sold $12.73M of Revolution Medicines, Inc. (RVMD) on the open market and bought none. All 9 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RVMDRevolution Medicines, Inc. | SVP & General Counsel | 13 | Sep 29 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-25
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | Sep 25 | Sep 29 | S | 765 | $207.32 | Sale −$158,600 | 51,776 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 16 | Sep 18 | S | 52 | $195.01 | Sale −$10,140 | 55,855 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 16 | Sep 18 | S | 3,314 | $199.30 | Sale −$660,491 | 52,541 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | M | 29,680 | $18.56 | $550,861 | 86,201 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | M | 26,600 | $21.61 | $574,826 | 112,801 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 3,400 | $207.24 | Sale −$704,603 | 109,401 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 17,323 | $208.37 | Sale −$3,609,573 | 92,078 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 25,817 | $209.25 | Sale −$5,402,200 | 66,261 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 2,540 | $210.26 | Sale −$534,072 | 63,721 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 4,500 | $211.34 | Sale −$951,038 | 59,221 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | S | 3,314 | $212.06 | Sale −$702,761 | 55,907 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | M · derivative | 29,680 | $18.56 | $550,861 | not reported | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 21 | Aug 25 | M · derivative | 26,600 | $21.61 | $574,826 | 3,500 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.